Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Januar 2021 08:30 ET | Quelle: Emerald Bioscience, Inc.

Emerald Bioscience to Present at the KCSA Cannabis Investor Conference

San Diego, Calif, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a biopharmaceutical company focused on developing differentiated, proprietary...
30. September 2020 08:30 ET | Quelle: Emerald Bioscience, Inc.

Emerald Bioscience Provides Corporate Update

Renewed team and capital focused on advancing lead compound for glaucoma into human studies Ongoing development of lead compound, THCVHS, includes near-term preclinical assessments of neuroprotection...
10. August 2020 08:30 ET | Quelle: Emerald Bioscience, Inc.

Emerald Bioscience Appoints Biotech Executive Punit Dhillon as CEO

Renewed team and capital focused on advancing lead compound for glaucoma into clinical development San Diego, Calif, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI)...
08. April 2020 08:30 ET | Quelle: Emerald Bioscience, Inc.

Emerald Bioscience Joins Alliance for Biosecurity

The Alliance is a government-industry consortium that is a leading voice on biosecurity issues in the United States Long Beach, Calif., April 08, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience,...